Recent advances in the management of age-related macular degeneration

Optometry and Vision Science

Volumn 79, Issue 4, 2002, Pages 218-224

  Mittra, Robert A ^a   Singerman, Lawrence J ^a  

^a Retina Associates of Cleveland   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Photodynamic therapy; Verteporfin therapy; Visudyne

Indexed keywords

COAGULATION; DRUG PRODUCTS; LASERS; PATIENT TREATMENT; PHOTODYNAMIC THERAPY;

DEGENERATION;

VISION;

BENZOPORPHYRIN DERIVATIVE; PLACEBO;

BACKACHE; CLINICAL TRIAL; CONTRAST SENSITIVITY; EARLY DIAGNOSIS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LASER COAGULATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; RETINA INJURY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT;

EID: 0036231472     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006324-200204000-00008     Document Type: Review

References (38)

1. Age-related macular degeneration
2. The Framingham Eye Study: I. Outline and major prevalence findings
3. Age-related macular degeneration and blindness due to neovascular maculopathy
4. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: Updated findings from two clinical trials
5. Age-related macular degeneration: The current understanding of the status of clinicopathology, diagnosis and management
6. Epidemiology of AMD
7. Age-related macular degeneration: A review of experimental treatments
8. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration
9. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization
10. Argon laser photocoagulation for senile macular degeneration: Results of a randomized clinical trial
11. Subfoveal neovascular lesions in age-related macular degeneration: Guidelines for evaluation and treatment in the Macular Photocoagulation Study
12. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials: TAP Report 1
13. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration
14. Argon laser photocoagulation for neovascular maculopathy: Five-year results from randomized clinical trials
15. Laser photocoagulation for juxtafoveal choroidal neovascularization: Five-year results from randomized clinical trials
16. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration
17. Photodynamic therapy
18. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials: TAP report 2
19. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: Verteporfin in Photodynamic Therapy Report 2
20. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes
21. Visual outcomes in patients with minimally classic choroidal neovasculaization (CNV): Rationale for the Visudyne in Minimally Classic CNV (VIM) trial
22. Treatment options in subfoveal choroidal neovascularization secondary to age-related macular degeneration
23. Radiation therapy for age-related macular degeneration
24. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: Radiation versus observation
25. Treatment of age-related subfoveal neovascular membranes by teletherapy: A pilot study
26. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study)
27. External beam radiation therapy for choroidal neovascularization
28. External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: A review of 111 cases
29. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration: Results of a prospective randomized placebo-controlled clinical trial
30. Medical therapy for macular degeneration
31. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration using verteporfin (Visudyne): Exploratory analysis of good visual outcomes: TAP Report #4
32. Earliest symptoms caused by neovascular membranes in the macula
33. Evaluation of screening schemes for eye disease in a primary care setting
34. Keeping an eye on vision: Primary care of age-related ocular disease: Part 1
35. Cross-sectional estimates of active life expectancy for the U.S. elderly and oldest-old populations